Jyoti Panicker, M.D.
Division of Pediatric Hematology/Oncology
- Blood disorders
- Sickle cell disease
- Bone tumors
Education and Training
- Maulana Azad Medical College, New Delhi, India: Doctor of medicine
- Children's Hospital of Michigan, Wayne State University, Detriot: Pediatrics residency
- Children's National Medical Center, Washington, D.C.: Pediatric hematology oncology fellowship
- Molecular Biology Laboratory of Carol J. Thiele, Ph.D., NCI National Institutes of Health, Bethesda, Md.: Research fellow
- Pediatric Academic Societies (PAS) Young Investigator's Travel Award at Pediatric Academic Societies/American Society of Pediatric Hematology Oncology annual meeting
- Sunflower fellowship, 2010-2012
- Leadership Development Scholarship, 2012
- American Society of Pediatric Hematology Oncology
- Kansas Chapter American Academy of Pediatrics
- 2003-05: In vitro and in vivo efficacy of Romidepsin (FK228/depsipeptide), a histone deacetylase inhibitor in Neuroblastoma and Ewing's Sarcoma. Molecular Biology Laboratory of Carol J Thiele, PhD, Principal Investigator, Pediatric Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland.
- 2005-07: Co-investigator, Children's Oncology Group protocols (70 clinical trials open at Tod Children's Hospital which were approved by Institutional Review Board).
- 2005-07: Co-investigator, Children's Oncology Group protocols (75 clinical trials open at Akron Children's Hospital which were approved by Institutional Review Board).
- 2009-10: Co-investigator, Children's Oncology Group protocols (50 clinical trials open at KUMC which were approved by Human Subjects Committee).
- 2011-present: Co-Investigator for Pediatric Cancer Survivors Survey Instrument Project - Childhood Cancer Adult Survivor Survey: Healthcare Practices and Needs Assessment- Children's Mercy and KUMC Survivorship Collaboration.
- Principal Investigator is Jennifer R Klemp, PhD, MPH.
- While the number of adult survivors of childhood cancer continues to grow (1 in 640 US adults), there is limited published data on the diagnosis-related and late effects of treatment information needs of this population. Having this data available will allow for the development of follow-up programming to address the ongoing physical and psycho-social needs of this population.
- 2010-present: Collaborative project with Dr. Kenneth Peterson (Professor & Vice-Chairman, KUMC Department of Biochemistry and Molecular Biology) studying correlation between zinc and Hemoglobin F in sickle cell disease. We are applying applied for a departmental grant for this project entitled, "In vivo and In vitro Effects of Zinc Supplementation on Hemoglobin F levels in Sickle Cell Disease".
Last modified: Apr 24, 2021